These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29468202)

  • 1. Pramipexole-induced antecollis in patients with Parkinson's disease: Two cases and literature review.
    Iijima M; Osawa M; Uchiyama S; Kitagawa K
    eNeurologicalSci; 2015 Jun; 1():21-23. PubMed ID: 29468202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine agonist-induced antecollis in Parkinson's disease.
    Uzawa A; Mori M; Kojima S; Mitsuma S; Sekiguchi Y; Kanesaka T; Kuwabara S
    Mov Disord; 2009 Dec; 24(16):2408-11. PubMed ID: 19890970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pramipexole-induced antecollis in Parkinson's disease.
    Suzuki M; Hirai T; Ito Y; Sakamoto T; Oka H; Kurita A; Inoue K
    J Neurol Sci; 2008 Jan; 264(1-2):195-7. PubMed ID: 17826796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible antecollis associated with pramipexole in a patient with Parkinson's disease.
    Kim HJ; Jeon BS; Kim SH; Han SH
    J Clin Neurosci; 2012 Jun; 19(6):903-4. PubMed ID: 22353251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and clinical correlates of retrocollis in Parkinson's disease.
    Kashihara K; Imamura T
    J Neurol Sci; 2013 Jan; 324(1-2):106-8. PubMed ID: 23151424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of pramipexole for motor function and depression in Parkinson's disease.
    Kano O; Ikeda K; Kiyozuka T; Iwamoto K; Ito H; Kawase Y; Sato R; Fujioka T; Araki Y; Baba S; Iwasaki Y
    Neuropsychiatr Dis Treat; 2008 Aug; 4(4):707-10. PubMed ID: 19043513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-generation dopamine agonists and recollection impairments in Parkinson's disease.
    Shepherd TA; Edelstyn NM; Mayes AR; Ellis SJ
    J Neuropsychol; 2013 Sep; 7(2):284-305. PubMed ID: 23815454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease.
    Linazasoro G;
    J Neurol; 2004 Mar; 251(3):335-9. PubMed ID: 15015015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phenomenon of disproportionate antecollis in Parkinson's disease and multiple system atrophy.
    van de Warrenburg BP; Cordivari C; Ryan AM; Phadke R; Holton JL; Bhatia KP; Hanna MG; Quinn NP
    Mov Disord; 2007 Dec; 22(16):2325-31. PubMed ID: 17960814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible effects of pramipexole on neck muscles in a patient with Parkinson's disease.
    Filippi R; Rasetti M; Lenzi M; Bright P
    Oxf Med Case Reports; 2014 Apr; 2014(1):8-10. PubMed ID: 25988008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophthalmologic Baseline Characteristics and 2-Year Ophthalmologic Safety Profile of Pramipexole IR Compared with Ropinirole IR in Patients with Early Parkinson's Disease.
    Seiple W; Jennings D; Rosen RB; Borchert L; Canale L; Fagan N; Gordon MF
    Parkinsons Dis; 2016; 2016():8298503. PubMed ID: 28078162
    [No Abstract]   [Full Text] [Related]  

  • 12. Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson's disease.
    Jiménez-Urbieta H; Gago B; Quiroga-Varela A; Rodríguez-Chinchilla T; Merino-Galán L; Oregi A; Belloso-Iguerategui A; Delgado-Alvarado M; Navalpotro-Gómez I; Marin C; Fernagut PO; Rodríguez-Oroz MC
    Neurobiol Aging; 2019 Mar; 75():126-135. PubMed ID: 30572183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of pramipexole dose-response relationships in Parkinson's disease.
    Wang Y; Sun SG; Zhu SQ; Liu CF; Liu YM; Di Q; Shang HF; Ren Y; Xiang W; Chen SD
    Drug Des Devel Ther; 2017; 11():83-89. PubMed ID: 28096656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect Comparison of Ropinirole and Pramipexole as Levodopa Adjunctive Therapy in Advanced Parkinson's Disease: A Systematic Review and Network Meta-Analysis.
    Zhao H; Ning Y; Cooper J; Refoios Camejo R; Ni X; Yi B; Parks D
    Adv Ther; 2019 Jun; 36(6):1252-1265. PubMed ID: 30963514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease: an evidence-based comparison.
    Inzelberg R; Schechtman E; Nisipeanu P
    Drugs Aging; 2003; 20(11):847-55. PubMed ID: 12964891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease.
    Lyons KE; Pahwa R
    Mov Disord; 2009 Oct; 24(14):2121-7. PubMed ID: 19768728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists.
    Rizos A; Sauerbier A; Antonini A; Weintraub D; Martinez-Martin P; Kessel B; Henriksen T; Falup-Pecurariu C; Silverdale M; Durner G; Røkenes Karlsen K; Grilo M; Odin P; Chaudhuri KR;
    Eur J Neurol; 2016 Aug; 23(8):1255-61. PubMed ID: 27170229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dropped head sign induced by transdermal application of the dopamine agonist rotigotine in parkinsonian syndrome: a case report.
    Dohm CP; Gröschel S; Liman J; Bähr M; Kermer P
    J Med Case Rep; 2013 Jul; 7():174. PubMed ID: 23829877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of pramipexole transdermal patch in the MPTP-induced mouse model of Parkinson's disease.
    Wang Y; Yu X; Zhang P; Ma Y; Wang L; Xu H; Sui D
    J Pharmacol Sci; 2018 Sep; 138(1):31-37. PubMed ID: 30241783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
    Utsumi H; Okuma Y; Kano O; Suzuki Y; Iijima M; Tomimitsu H; Hashida H; Kubo S; Suzuki M; Nanri K; Matsumura M; Murakami H; Hattori N;
    Intern Med; 2013; 52(3):325-32. PubMed ID: 23370739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.